ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2022. FOURTH-QUARTER FINANCIAL...

Related Keywords

Canada ,Dublin ,Ireland ,Canadian , ,Prnewswire Endo International ,Branded Pharmaceuticals ,Paladin Labs Inc ,Linkedin ,Generic Pharmaceuticals ,Endo Investor Relations Department ,Exchange Commission ,International Pharmaceuticals ,Pfizer Inc ,Endo International ,Company Loss ,Company Chapter ,Months Ended December ,Ended December ,Diluted Net Loss ,Continuing Operations ,Diluted Weighted Average Shares ,Diluted Net Income ,Adjusted Diluted Weighted Average Shares ,Adjusted Income ,Adjusted Diluted Net Income ,Sterile Injectables ,Endo Aesthetic ,Nasal Spray ,Paladin Labs ,Condensed Consolidated Statement ,Condensed Consolidated Balance Sheet ,Cash Flow ,Qualified Settlement ,Current Report ,Supplemental Financial Information ,Consolidated Statements ,Accounting Standards Codification Topic ,Private Securities Litigation Reform Act ,Bankruptcy Code ,Annual Report ,Quarterly Reports ,Endo International Plc ,Otc ,Mallcap ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Earnings ,Earnings Forecasts Amp Projections ,